» Articles » PMID: 33763367

Impact of Multidisciplinary Team Management on the Survival Rate of Head and Neck Cancer Patients: A Cohort Study Meta-analysis

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Mar 25
PMID 33763367
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Head and neck cancer (HNC) is one of the more common malignant tumors that threaten human health worldwide. Multidisciplinary team management (MDTM) in HNC treatment has been introduced in the past several decades to improve patient survival rates. This study reviewed the impact of MDTM on survival rates in patients with HNC compared to conventional treatment methods. Only cohort studies were identified for this meta-analysis that included an exposure group that utilized MDTM and a control group. Heterogeneity and sensitivity also were assessed. Survival rate data for HNC patients were analyzed using RevMan 5.2 software. Five cohort studies ( = 39,070) that examined survival rates among HNC patients were included. Hazard ratios (HR) were calculated using the random effect model. The results revealed that exposure groups treated using MDTM exhibited a higher survival rate [HR = 0.84, 95% CI (0.76-0.92), = 0.0004] with moderate heterogeneity ( = 68%, = 0.01). For two studies that examined the effect of MDTM on the survival rate for patients specifically with stage IV HNC, MDTM did not produce any statistically significant improvement in survival rates [HR = 0.81, 95% CI (0.59-1.10), = 0.18]. The application of MDTM based on conventional surgery, radiotherapy, and chemotherapy improved the overall survival rate of patients with HNC. Future research should examine the efficacy of MDTM in patients with cancer at different stages.

Citing Articles

Developing a framework for estimating comorbidity burden of inpatient cancer patients based on a case study in China.

Wang J, Zhang W, Sun K, Su M, Zhang Y, Su J Glob Health Res Policy. 2025; 10(1):13.

PMID: 40033407 PMC: 11874831. DOI: 10.1186/s41256-025-00411-3.


Significance of Multidisciplinary Teams for Patients with Oral and Maxillofacial Surgical Diseases: An Observational Retrospective Study in a General Hospital in China.

Chen J, Yao Q, Wang X, Jiang J, Zhu H, Yu D J Multidiscip Healthc. 2025; 17:6187-6198.

PMID: 39759085 PMC: 11697645. DOI: 10.2147/JMDH.S504720.


The Role of Single Nucleotide Polymorphisms in MicroRNA Genes in Head and Neck Squamous Cell Carcinomas: Susceptibility and Prognosis.

Szmida E, Butkiewicz D, Karpinski P, Rutkowski T, Oczko-Wojciechowska M, Sasiadek M Genes (Basel). 2024; 15(9).

PMID: 39336817 PMC: 11431317. DOI: 10.3390/genes15091226.


Lower survival for surgical treatment of human papillomavirus-related oropharynx cancer at community cancer centers.

Trakimas D, Mydlarz W, Mady L, Gourin C, Koch W, London Jr N J Natl Cancer Inst. 2024; 117(3):423-435.

PMID: 39250754 PMC: 11884852. DOI: 10.1093/jnci/djae220.


Impact of Preoperative Multidisciplinary Conference on Head and Neck Reconstruction Outcomes.

Dang S, Hashimi B, Tang A, Kubik M, Solari M, Sridharan S Laryngoscope. 2024; 135(1):110-117.

PMID: 39077976 PMC: 11635136. DOI: 10.1002/lary.31665.


References
1.
Taghavi N, Yazdi I . Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med. 2015; 18(5):314-9. DOI: 0151805/AIM.0010. View

2.
Taylor C, Atkins L, Richardson A, Tarrant R, Ramirez A . Measuring the quality of MDT working: an observational approach. BMC Cancer. 2012; 12:202. PMC: 3489862. DOI: 10.1186/1471-2407-12-202. View

3.
Tsai W, Kung P, Wang S, Huang K, Liu S . Beneficial impact of multidisciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan. Oral Oncol. 2014; 51(2):105-11. DOI: 10.1016/j.oraloncology.2014.11.006. View

4.
Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. DOI: 10.1001/jama.283.15.2008. View

5.
Taylor C, Munro A, Glynne-Jones R, Griffith C, Trevatt P, Richards M . Multidisciplinary team working in cancer: what is the evidence?. BMJ. 2010; 340:c951. DOI: 10.1136/bmj.c951. View